ATE187169T1 - 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate - Google Patents

6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate

Info

Publication number
ATE187169T1
ATE187169T1 AT95935997T AT95935997T ATE187169T1 AT E187169 T1 ATE187169 T1 AT E187169T1 AT 95935997 T AT95935997 T AT 95935997T AT 95935997 T AT95935997 T AT 95935997T AT E187169 T1 ATE187169 T1 AT E187169T1
Authority
AT
Austria
Prior art keywords
pct
polyfluoralkoxy
polyfluoralkyl
benzothiazole derivatives
amino benzothiazole
Prior art date
Application number
AT95935997T
Other languages
English (en)
Inventor
Philip Chapelle
Claude Gaillard
Patrick Jimonet
Erik Louvel
Michel Martinet
Serge Mignani
Gerard Sanderink
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of ATE187169T1 publication Critical patent/ATE187169T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cephalosporin Compounds (AREA)
AT95935997T 1994-10-26 1995-10-23 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate ATE187169T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9412796A FR2726271B1 (fr) 1994-10-26 1994-10-26 Derives de 6-polyfluoroalcoxy-2-aminobenzothiazole

Publications (1)

Publication Number Publication Date
ATE187169T1 true ATE187169T1 (de) 1999-12-15

Family

ID=9468224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95935997T ATE187169T1 (de) 1994-10-26 1995-10-23 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate

Country Status (12)

Country Link
US (1) US5795903A (de)
EP (1) EP0788491B1 (de)
JP (1) JP3882198B2 (de)
AT (1) ATE187169T1 (de)
AU (1) AU3809095A (de)
DE (1) DE69513679T2 (de)
DK (1) DK0788491T3 (de)
ES (1) ES2139247T3 (de)
FR (1) FR2726271B1 (de)
GR (1) GR3032022T3 (de)
WO (1) WO1996013492A1 (de)
ZA (1) ZA958861B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6017903A (en) 1996-09-27 2000-01-25 Guilford Pharmaceuticals Inc. Pharmaceutical compositions and methods of treating a glutamate abnormality and effecting a neuronal activity in an animal using NAALADase inhibitors
US5824662A (en) 1996-09-27 1998-10-20 Guilford Pharmaceuticals Inc. Treatment of global and focal ischemia using naaladase inhibitors
KR20000036227A (ko) 1996-09-27 2000-06-26 토마스 씨. 서 날라다아제조성물, 글루탐산염 이상 치료법 및 동물내의 뉴우런활성법
FR2774592B1 (fr) * 1998-02-06 2000-03-17 Rhone Poulenc Rorer Sa Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet
DE60220678T2 (de) * 2001-08-13 2008-03-06 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Hemmer der aggregation von polyq
WO2004098494A2 (en) * 2003-04-30 2004-11-18 Cytokinetics, Inc. Compounds, compositions, and methods
US8710088B2 (en) * 2004-02-11 2014-04-29 Max-Delbruck-Centrum Fur Molekulare Medizin Pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases
EP3601235B1 (de) 2017-03-30 2026-03-04 XWPharma Ltd. Bicyclische heteroarylderivate, deren herstellung und therapeutischen verwendungen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2492258A1 (fr) * 1980-10-17 1982-04-23 Pharmindustrie Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole
DE68901859T2 (de) * 1988-12-15 1993-01-14 Rhone Poulenc Sante 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
FR2649701B2 (fr) * 1988-12-15 1991-11-22 Rhone Poulenc Sante Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant
US5236940A (en) * 1988-12-15 1993-08-17 Rhone-Poulenc Sante Pharmaceutical compositions, 2-benzothiazolamine derivatives, and their preparation

Also Published As

Publication number Publication date
EP0788491B1 (de) 1999-12-01
FR2726271B1 (fr) 1996-12-06
JP3882198B2 (ja) 2007-02-14
US5795903A (en) 1998-08-18
ES2139247T3 (es) 2000-02-01
DE69513679T2 (de) 2000-06-21
ZA958861B (en) 1996-05-09
DK0788491T3 (da) 2000-05-08
AU3809095A (en) 1996-05-23
EP0788491A1 (de) 1997-08-13
JPH10508014A (ja) 1998-08-04
FR2726271A1 (fr) 1996-05-03
DE69513679D1 (de) 2000-01-05
WO1996013492A1 (fr) 1996-05-09
GR3032022T3 (en) 2000-03-31

Similar Documents

Publication Publication Date Title
DK0874812T3 (da) Hidtil ukendte 2,3,5-trimethyl-4-hydroxyanilidderivater, fremstilling deraf og terapeutisk anvendelse deraf
DK0766696T3 (da) Thiazolidinderivater, fremstilling af disse forbindelser og lægemidler indeholdende disse forbindelser
AU2936195A (en) Cyclic amide derivatives for protecting against ultraviolet rays
PT91574A (pt) Procede de preparation de n-cycloalkyle benzyamines utiles comme medicaments
KR900006347A (ko) 살균성 플루오로퀴놀로닐 세펨
ATE187169T1 (de) 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate
IT1196423B (it) Benzotiazolin-composti
HUT77768A (hu) N-szubsztituált azabicikloheptánszármazékok, eljárás előállításukra és alkalmazásuk
AU7899891A (en) Compounds for the treatment of age-related memory impairment and other cognitive disorders
MX9101948A (es) Composicion farmaceutica que contiene derivados de tiazoloisoindolinona
ATE181734T1 (de) N-benzoylmethylsubstituierte paroxetinderivate
DE69312512D1 (de) Etoposid-derivate, ihre herstellung, ihre verwendung als medikament und ihre verwendung zur herstellung eines antikrebsmittels
DE69919191D1 (de) Heilmittel für die stenose des rückenmarkkanals
DE69131353D1 (de) Indolderivate
ATE205853T1 (de) Streptograminderivate, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
GR3005533T3 (de)
ATE63309T1 (de) 2,3-dihydro-2-oxo-3-benzofuranylessigs|urederivate und diese enthaltende arzneimittel.
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
AU4544096A (en) New derivatives of glycylanilides, preparation and therapeutical application

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification